rhenium has been researched along with EHS Tumor in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chu, T; Mei, L; Wang, Y | 1 |
| Cerecetto, H; Giglio, J; González, M; León, E; Papadopoulos, M; Patsis, G; Pelecanou, M; Pirmettis, I; Raptopoulou, C; Rey, A | 1 |
2 other study(ies) available for rhenium and EHS Tumor
| Article | Year |
|---|---|
⁹⁹mTc/Re complexes bearing bisnitroimidazole or mononitroimidazole as potential bioreductive markers for tumor: synthesis, physicochemical characterization and biological evaluation.
Topics: Animals; Biomarkers, Tumor; Chemistry, Physical; Electrochemical Techniques; Mice; Mice, Inbred Strains; Molecular Structure; Nitroimidazoles; Organometallic Compounds; Oxidation-Reduction; Rats; Rhenium; Sarcoma, Experimental; Technetium; Tissue Distribution | 2012 |
Preparation and characterization of technetium and rhenium tricarbonyl complexes bearing the 4-nitrobenzyl moiety as potential bioreductive diagnostic radiopharmaceuticals. In vitro and in vivo studies.
Topics: Animals; Cell Hypoxia; Crystallography, X-Ray; Diagnostic Imaging; In Vitro Techniques; Liver; Lung; Mice; Models, Molecular; Molecular Structure; Organotechnetium Compounds; Radiopharmaceuticals; Rhenium; Sarcoma, Experimental; Spectrophotometry, Infrared; Structure-Activity Relationship; Tissue Distribution; Xenograft Model Antitumor Assays | 2008 |